Stryker (NYSE: SYK) Scrutinized Amid Disclosure of Persisting Peripheral Vascular Problems -- HBSSPRNewsWire • 20m
Stryker (SYK) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • Thursday
SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?Zacks Investment Research • Wednesday
Countdown to Stryker (SYK) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • Monday
Stryker (SYK) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/22/26
Stryker's Sonopet 3 Secures FDA Clearance to Improve Surgical AccuracyZacks Investment Research • 10/21/26
Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmGlobeNewsWire • 10/15/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYKPRNewsWire • 10/15/26
Stryker Corporation (SYK) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationGlobeNewsWire • 10/15/26
Securities Fraud Investigation Into Stryker Corporation (SYK) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzGlobeNewsWire • 10/14/26